These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 720780)

  • 1. Lack of gastrointestinal glucagon response to hypoglycaemia in depancreatized dogs.
    Matsuyama T; Tanaka R; Shima K; Nonaka K; Tarui S
    Diabetologia; 1978 Dec; 15(6):471-4. PubMed ID: 720780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of glucagon deficiency in the Houssay phenomenon of dogs.
    Nakabayashi H; Dobbs RE; Unger RH
    J Clin Invest; 1978 May; 61(5):1355-62. PubMed ID: 659597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of hypophysectomy and hypophysis-transplantation on the secretion of gut glucagon immunoreactivity and gut glucagon-like immunoreactivity in depancreatized dogs.
    Yoshida T; Kondo M
    Endocrinol Jpn; 1980 Feb; 27(1):77-81. PubMed ID: 6248336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrapancreatic glucagon in control of glucose turnover in depancreatized dogs.
    Ross G; Lickley L; Vranic M
    Am J Physiol; 1978 Feb; 234(2):E213-19. PubMed ID: 623297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extrapancreatic glucagon and glucagonlike immunoreactivity in depancreatized dogs. A quantitative assessment of secretion rates and anatomical delineation of sources.
    Muller WA; Girardier L; Seydoux J; Berger M; Renold AE; Vranic M
    J Clin Invest; 1978 Jul; 62(1):124-32. PubMed ID: 659625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent pancreatic glucagon but not insulin response to arginine in pancreatectomized dogs.
    Mashiter K; Harding PE; Chou M; Mashiter GD; Stout J; Diamond D; Field JB
    Endocrinology; 1975 Mar; 96(3):678-93. PubMed ID: 1116479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The essentiality of insulin and the role of glucagon in regulating glucose utilization and production during strenuous exercise in dogs.
    Vranic M; Kawamori R; Pek S; Kovacevic N; Wrenshall GA
    J Clin Invest; 1976 Feb; 57(2):245-55. PubMed ID: 1254723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in blood glucose and release of gut glucagon-like immunoreactive materials by bombesin infusion in the dog.
    Matsuyama T; Namba M; Nonaka K; Tarui S; Tanaka R; Shima K
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():115-9. PubMed ID: 7014201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of plasma glucagon immunoreactivity in normal, depancreatized, and alloxan-diabetic dogs.
    Valverde I; Dobbs R; Unger RH
    Metabolism; 1975 Sep; 24(9):1021-8. PubMed ID: 1152674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acetylcholine on the secretion of gut glucagon immunoreactivity and gut glucagon-like immunoreactivity in pancreatectomized dogs.
    Yoshida T; Kondo M
    Endocrinol Jpn; 1980 Feb; 27(1):33-8. PubMed ID: 6993193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of extrapancreatic glucagon to glycemic changes.
    Ohneda A; Kobayashi T; Nihei J
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():121-6. PubMed ID: 7014202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of extrapancreatic glucagon to arginine in dogs.
    Ohneda A; Kobayashi T; Nihei J; Umezu M; Sakai T; Sanoyama K
    Tohoku J Exp Med; 1979 Sep; 129(1):45-54. PubMed ID: 494257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of insulin-induced hypoglycaemia on the secretion of glucagon and hepatic glucose production in pancreatectomized dogs.
    Lussier B; Hetenyi G
    Can J Physiol Pharmacol; 1986 Nov; 64(11):1440-2. PubMed ID: 3539287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of exogenously administered glucagon on plasma glucose levels in totally depancreatized dogs.
    Nishimura I; Sudo T; Konishi K; Suzuki T; Tobe T; Nakagawa M; Nakase A
    Gastroenterol Jpn; 1978; 13(6):468-79. PubMed ID: 748092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of somatostatin to decrease blood glucose by suppression of extrapancreatic glucagon in severely diabetic depancreatized dogs.
    Matsuyama T; Tanaka R; Shima K; Tarui S
    Endocrinol Jpn; 1978 Dec; 25(6):529-32. PubMed ID: 751798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of extrapancreatic glucagon to gastrointestinal hormones in pancreatectomized dogs.
    Ohneda A; Kobayashi T; Nihei J
    Tohoku J Exp Med; 1985 Aug; 146(4):439-47. PubMed ID: 3907014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change of glucagon reacting to 30 K antibody in totally depancreatized dogs.
    Sudo T; Konishi K; Nakase A; Suzuki T; Nishimura I; Tobe T
    Gastroenterol Jpn; 1978; 13(2):119-26. PubMed ID: 669196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of extrapancreatic immunoreactive glucagon to intraluminal nutrients in pancreatectomized dogs.
    Ohneda A; Kobayashi T; Nihei J
    Horm Metab Res; 1984 Jul; 16(7):344-8. PubMed ID: 6386643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose.
    Unger RH; Ohneda A; Valverde I; Eisentraut AM; Exton J
    J Clin Invest; 1968 Jan; 47(1):48-65. PubMed ID: 5638120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement and partial characterization of immunoreactive glucagon in gastrointestinal tissues of dogs.
    Morita S; Doi K; Yip CC; Vranic M
    Diabetes; 1976 Nov; 25(11):1018-25. PubMed ID: 186345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.